The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry - PubMed (original) (raw)
Clinical Trial
The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry
J A W M van der Laak et al. J Clin Pathol. 2002 Jun.
Abstract
Background: After the menopause decreased concentrations of oestrogen may result in insufficient maturation of the vaginal epithelium, which can lead to a range of vaginal discomforts. This state of vaginal atrophy may be treated with oestrogen replacement treatment. Replens, a non-hormonal alternative to oestrogen replacement treatment has been shown to be effective in relieving symptoms related to vaginal atrophy in previous studies.
Aims: To study the effect of Replens on the maturation of the vaginal epithelium and morphology of the vaginal cells and to compare the results of a recently developed cytomorphometric method with manual assessment of the degree of maturation in vaginal smears.
Methods: Vaginal smears from 38 postmenopausal women suffering from symptoms related to vaginal atrophy were analysed manually and by cytomorphometry. The maturation value (MV) and the percentages of (para)basal, intermediate, and superficial cells (maturation index; MI) were measured by both methods before and after treatment with Replens. Cytomorphometry also measured mean cellular area, mean nuclear area, and mean area ratio.
Results: A correlation was shown between the two methods in the assessment of percentages of (para) basal and intermediate cells and MV. Cytomorphometric data showed a significant increase in mean cellular area, indicating a positive effect of Replens on the maturation of the vaginal epithelium. Changes in nuclear area and ratio between nuclear and cellular areas were not significant. Treatment with Replens did not influence MI or MV, as assessed by the two methods.
Conclusions: Replens did have an effect on vaginal morphology. The automated procedure may be useful for the assessment of maturation in vaginal smears and is more sensitive to small (subvisual) changes.
Figures
Figure 1
Comparison between automated and manual assessment of baseline values for (A) the percentage of (para)basal cells and (B) the maturation value.
Figure 2
Difference between post treatment and baseline values for (A) the percentage of (para)basal cells, (B) the maturation value, and (C) the cellular area. The solid lines indicate the median values over all cases.
Figure 3
Randomly selected microscopical images of haematoxylin and eosin stained smears from three women with a pronounced increase in cellular area, as assessed by cytomorphometric analysis. Patients 1 (A, B), 2 (C, D), and 3 (E, F) at baseline (A, C, E) and post treatment (B, D, F).
Similar articles
- Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
Bygdeman M, Swahn ML. Bygdeman M, et al. Maturitas. 1996 Apr;23(3):259-63. doi: 10.1016/0378-5122(95)00955-8. Maturitas. 1996. PMID: 8794418 Clinical Trial. - The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
Zohrabi I, Abedi P, Ansari S, Maraghi E, Shakiba Maram N, Houshmand G. Zohrabi I, et al. BMC Womens Health. 2020 May 19;20(1):108. doi: 10.1186/s12905-020-00935-5. BMC Womens Health. 2020. PMID: 32429977 Free PMC article. Clinical Trial. - Comparative study: Replens versus local estrogen in menopausal women.
Nachtigall LE. Nachtigall LE. Fertil Steril. 1994 Jan;61(1):178-80. doi: 10.1016/s0015-0282(16)56474-7. Fertil Steril. 1994. PMID: 8293835 Clinical Trial. - The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society. North American Menopause Society. Menopause. 2007 May-Jun;14(3 Pt 1):355-69; quiz 370-1. doi: 10.1097/gme.0b013e31805170eb. Menopause. 2007. PMID: 17438512 - Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J, Lethaby A, Kennedy R. Suckling J, et al. Cochrane Database Syst Rev. 2003;(4):CD001500. doi: 10.1002/14651858.CD001500. Cochrane Database Syst Rev. 2003. PMID: 14583935 Updated. Review.
Cited by
- Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India.
Ulhe SC, Acharya N, Vats A, Singh A. Ulhe SC, et al. Cureus. 2024 Feb 24;16(2):e54802. doi: 10.7759/cureus.54802. eCollection 2024 Feb. Cureus. 2024. PMID: 38529421 Free PMC article. - Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review.
Moccia F, Pentangelo P, Ceccaroni A, Raffone A, Losco L, Alfano C. Moccia F, et al. Aesthetic Plast Surg. 2023 Dec;47(6):2788-2799. doi: 10.1007/s00266-023-03550-5. Epub 2023 Aug 14. Aesthetic Plast Surg. 2023. PMID: 37580562 - Genistein anticancer efficacy during induced oral squamous cell carcinoma: an experimental study.
Hussein AM, Attaai AH, Zahran AM. Hussein AM, et al. J Egypt Natl Canc Inst. 2022 Sep 5;34(1):37. doi: 10.1186/s43046-022-00140-5. J Egypt Natl Canc Inst. 2022. PMID: 36058937 - Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM. Lubián López DM. World J Clin Oncol. 2022 Feb 24;13(2):71-100. doi: 10.5306/wjco.v13.i2.71. World J Clin Oncol. 2022. PMID: 35316932 Free PMC article. Review. - Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study.
Berreni N, Salerno J, Chevalier T, Alonso S, Mares P. Berreni N, et al. BMC Womens Health. 2021 Aug 28;21(1):322. doi: 10.1186/s12905-021-01435-w. BMC Womens Health. 2021. PMID: 34454465 Free PMC article.
References
- Kaufman RH, Friedrich EG, Gardner HL. Atrophic, desquamative, and postradiation vulvovaginitis. In: Benign diseases of the vulva and vagina. Chicago: Year book medical publishers, 1989:419–24.
- Nachtigall LE. Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 1994;61:178–80. - PubMed
- Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996;23:259–63. - PubMed
- Hubbard GB, Carey KD Levine H, et al. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function. Lab Anim Sci 1997;47:36–9. - PubMed
- Gelfand MM, Wendman E. Treating vaginal dryness in breast cancer patients: results of applying a polycarbophil moisturizing gel. J Womens Health 1994;3:427–34.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources